针刺治疗抑郁症共病慢性肌肉骨骼疼痛:随机对照试验研究方案
患者接受8周干预,随访4周,主要结局为HAMD-17和BPI评估的抑郁与疼痛严重程度。
要点
- 真针刺与假针刺对照,评估针刺对抑郁共病慢性疼痛的疗效。
- 主要结局为HAMD-17抑郁严重程度和BPI疼痛评分。
- 次要结局包括认知功能、生活质量和BDNF相关性。
核心结论
- 本研究旨在评估针刺治疗抑郁症共病慢性肌肉骨骼疼痛的临床疗效及潜在机制。
研究设计与样本
- 随机、假针刺对照、三臂试验,包括真针刺组、假针刺组和健康对照组。
- 患者接受8周干预,随后4周随访;健康对照组不接受干预。
关键数值与推荐
- 主要结局指标为HAMD-17评估的抑郁严重程度和BPI评估的疼痛严重程度。
- 次要结局指标包括MoCA、P300和WHOQOL-BREF评估的认知功能与生活质量。
- 还将测定脑源性神经营养因子(BDNF)与症状的相关性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Depression and chronic musculoskeletal pain (CMSP) are the leading causes of years lived with disabling diseases worldwide. Moreover, they often commonly coexist, which makes diagnosis and treatment difficult. A safe and effective treatment is urgently needed. Previous studies have shown that acupuncture is a cost-effective treatment for simple depression or CMSP. However, there is limited evidence that acupuncture is effective for depression comorbid with CMSP. METHODS: This is a randomized, sham acupuncture-controlled trial with three arms: real acupuncture (RA), sham acupuncture (SA), and healthy control (HC). Forty-eight depression combined CMSP participants and 12 healthy people will be recruited from GDTCM hospital and randomized 2:2:1 to the RA, SA, and HC groups. The patients will receive RA or SA intervention for 8 weeks, and HC will not receive any intervention. Upon completion of the intervention, there will be a 4-week follow-up. The primary outcome measures will be the severity of depression and pain, which will be assessed by the Hamilton Depression Rating Scale (HAMD-17) and Brief Pain Inventory (BPI), respectively. The secondary outcome measures will be cognitive function and quality of life, which will be measured by the Montreal Cognitive Assessment (MoCA), P300, and World Health Organization Quality of Life (WHOQOL-BREF). In addition, the correlation between brain-derived neurotrophic factor (BDNF) and symptoms will also be determined. DISCUSSION: The aim of this study is to evaluate the clinical efficacy and underlying mechanism of acupuncture in depression comorbid with CMSP. This study could provide evidence for a convenient and cost-effective means of future prevention and treatment of combined depression and CMSP. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1800014754 . Preregistered on 2 February 2018. The study is currently recruiting.
引用
- Li S, Liu J, Huang J, et al. Acupuncture for comorbid mild-moderate depression and chronic musculoskeletal pain: study protocol for a randomized controlled trial. Trials. 2021. PMID: 33926511. doi:10.1186/s13063-021-05260-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。